Osteocalcin(OC) is a specific serum p arameter of bone formation. Since bone metabolism disturbances, including osteoporosis, are seen in paraplegia, the serum levels of OC, midregional parathyroid hormone(mPTH), intact para thyroid hormone (iPTH) and calcitonin (CT) serum levels were determined in 13 patients with paraplegia or tetraplegia and 15 control subjects by radioimmuno assay in a cross sectional study. In addition, the urinary hydroxyproline/creatine and the urinary calcium/creatinine ratio was determined. Serum OC levels were significantly increased in the patients with spinal cord injury (p < 0.02), whereas serum levels of mPTH, iPTH and CT were not statistically different.
Introduction
Alterations in bone metabolism including osteoporosis, hypercalciuria and an in creased hydroxyproline excretion are fre quent findings in patients with spinal cord injuries. [1] [2] [3] [4] Periarticular ossification and urinary tract stone formation reflecting dis turbed calcium homeostasis can present major clinical problems delaying rehabilita tion.
Osteocalcin (OC, bone gla-protein) is a 49-amino acid protein, which is synthesised by the osteoblasts and can be measured in the t eripheral blood by radioimmunoas say. Serum levels of OC have been found to be a specific noninvasive parameter of osteoblast activity and bone formation in various endocrine disorders, postmeno-*Correspondence: Dr P Pils.
pausal osteoporosis and normal subjects as well. [6] [7] [8] In order to gain further insight into bone metabolism alterations following spinal cord injury, it was of interest to determine serum-OC levels in paraplegic and intetra plegic patients, both in a cross sectional and a follow up study design.
Subjects and methods
Cross sectional study Thirteen male patients (mean age 30.5 + 6.1 years) with complete paraplegia or tetraple gia (C4-Ll) 4 to 812 weeks (median 61. 5 weeks) after traumatic spinal cord injury were studied. All patients were previously healthy. Routine blood chemistry including plasma calcium, plasma phosphorus levels, liver and renal function tests was normal in SUbjects. All but one patient had vertebral luxation or fracture and only one patient had poly trauma (46 weeks p reviously). All patients fed by mouth and had no special diet. Recently injured patients were treated with bedrest. Full time wheel chair mobilisa tion was achieved in all subjects within a period of 2 to 4 months after injury, depending on the level of spinal cord lesion.
Follow up study
Six male patients (mean age 31.1 years, range 18-51) were selected according to the following criteria: (1) the previously healthy patients had been admitted to the Rehabili tation Center within one month after the traumatic spinal cord injury; (2) no other relevant bony lesions were present. All 6 patients had complete paraplegia or tetra plegia on admission (C5, C7, T5, TlO, Tl2, L2). One patient (L2) recovered from para plegia 4 months after injury; the data obtained from this paraparetic patient after recovering were excluded from the analysis. Blood samples were taken at monthly in tervals begining one month after the acci dent, for a follow up period of 6 months. For technical reasons 2 blood samples were missing in one patient (T5).
Controls: blood parameters were studied in 15 healthy male volunteers, mean age 32.1 + 4.7 years and urine samples were provided from 8 of them.
Methods
Blood samples were obtained at 08.00 hours from all patients and control subjects after an overnight fast.
Serum levels of osteocalcin (OC) were determined using a radioimmunoassay kit manufactured by CIS International (Gif sur Yvette, France) as previously described7 and serum calcitonin (CT) was measured using a RIA kit purchased from Immuno Nuclear (Stillwater, USA). Serum PTH was measured both by a RIA with midregion specificity using synthetic human PTH (43-68) as tracer and standard, mPTH (Sorin Biomedica, Milano, Italia) and a RIA specific for the intact PTH molecule, iPTH (Nichols Institute, San Juan Capi strano, CA, USA).9 All RIAs had intra assay coefficients of variance in the useful range of the assay less than 8% and interassay coefficients less than 14%. The minimal detectable concentration of OC was 0.2 ng/ml; that of mPTH 20 pmoljI; that of iPTH 2 pg/ml and that of CT 13 pg/ml.
In the follow up study serum levels of OC and iPTH were determined as described above.
Urine samples were obtained from pati ents and control subjects after an overnight fast. A 3-hour collecting period from 06.00 to 09.00 hours was chosen in the present study for the convenience of patients and controls. Urine was collected either by a suprapubic catheter, intermittent catheter isation or by reflex voiding followed by a single catheterisation in order to empty the bladder completely. In the literature a very close correlation between the postabsorp tive hydroxyproline/creatinine ratio and the 24-hour hydroxyproline excretion has been described. 1 0
Hydroxyproline (HYPRO) concentration in the 3-hour fasting urine was determined by strong acid cation exchange resin (Hypronosticon, Organon Teknika, Boxta, Netherlands)l 1 and the HYPRO/creatinine ratio was calculated. 1 0 Urinary calcium concentration in the 3-hour fasting urine was determined using a standard colorimetric procedure (Astra4, Beckman Instruments, USA), and the urin ary calcium/creatinine ratio was calcul ated. 1 2 In the follow up study urinary samples were obtained as described above at monthly intervals over a period of 5 months.
Statistics
In order to compare the patients' group of the cross sectional study with their controls the Wilcoxon 2 sample test and the Kruskal Wallis test were used. To refute Ho (no difference between the two groups) an error probability of less than 2% was assumed, even when p values were lower.
In order to correlate the duration of paraplegia with the p arameters of bone metabolism in the cross sectional study the Kendall Tau correlation coefficient was used.
Unless otherwise indicated data in the text and the tables are given as mean + SD.
Results
Cross sectional study Serum levels of OC, mPTH, iPTH and CT in the 13 patients with paraplegia or tetra plegia and the controls are shown in Table I . Serum OC levels were significantly in creased (p < 0.02) in the patients when compared with the controls. Serum mPTH and CT levels in the patients were not statistically different from the control group. Mean iPTH values were somewhat lower in the whole group of paraplegic and tetraplegic patients, but did not differ signi ficantly. The urinary HYPRO/creatinine ratio was significantly higher in the patients with paraplegia or tetraplegia than in the control subjects (p < 0.02) and urinary cal cium/creatinine ratio was also higher in the patients than in the controls; however the differences did not reach statistical signif icance (Table II) .
When the patients were subdivided into paraplegic and tetraplegic groups the bio chemical bone metabolism parameters were similar (Table III) .
When the paraplegic and tetraplegic pati ents were subdivided into those studied less than and into those studied more than one year after spinal cord injury, serum iPTH levels were higher and the HYPRO/creati nine ratio was lower in the patients with longterm disease (Table IV) .
In the whole group of patients a signifi cant positive correlation between the dura tion of p ara p legia and serum iPTH levels (tau = 0.56, p < 0.01) but not with OC (tau = -0.11), mPTH(tau = 0.20), CT (tau = -0.23) and the urinary calcium/crea tinine ratio (tau = -0.42) could be found. Urinary HYPRO/creatinine ratio correlated negatively with the duration of disease (tau = -0.69, p < 0.002).
Follow up study
The serum levels of OC, iPTH and the urinary HYPRO/creatinine and calcium/ creatinine ratio are shown in Figures 1 and  2 . One month after the spinal cord injury serum OC levels were normal; subsequently a continuous increase to levels considerably above the normal range was observed. Serum iPTH-levels were lowest one to 4 months after the injury and tended to increase thereafter. Urinary HYPRO/creatinine ratio was al ways manifold higher than in the controls. Urinary calcium/creatinine ratio during the entire follow up period was at least threefold higher than the mean control value.
Discussion
The data of the cross-sectional study de monstrate increased serum osteocalcin and increased urinary hydroxyproline excretion in patients with paraplegia or tetraplegia. In the follow up study serum OC levels were normal one month after injury, but in creased continuously thereafter. In contrast to the OC levels urinary HYPRO/creatinine ratio was already increased at the beginning of the follow up study.
Our data of an elevated hydroxyproline
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Figure 1 Serum osteocalcin (OC) and serum intakt parathyroid hormone (iPTH) in the para plegic or tetraplegic patients. (n) = number of patients; the thick horizontal bars indicate the values of the control subjects. The data are given as the mean ± SD.
excretion in paraplegia, which is in accord ance with the literature,4,13 indicates an increased bone resorption in the patients studied. Furthermore, the follow up study demonstrates that bone resorption (ie hyperhydroxyprolinuria) precedes the in crease of osteoblastic activity (ie hyper osteocalcinaemia). Thus bone metabolism in the patients studied might resemble the high turnover model of postmenopausal osteoporosis, where an accelerated bone resorption exceeds the increased bone for mation. The serum levels of iPTH which are considered to represent the biologically active PTH seemed suppressed in the early p eriod after the injury but showed a ten dency to increase after 6 months in accordReferences ance with the positive correlation between the serum iPTH levels and the duration of paraplegia in the cross sectional study. The urinary calcium/creatinine ratio was at least threefold higher in the half year follow up period after spinal cord injury than the mean control value; similarily in the cross sectional study urinary calcium excretion was higher in the patients than in the controls. These data are in accordance with Stewart et at who found low PTH levels and hypercalciuria in paraplegia. 14 Obvi ously, the changes in bone resorption of our patients are more pronounced than in heal thy immobilised subjects 15 and it should be stressed that despite mobilisation of the paraplegic nad tetraplegic patients the lack of muscle activity on the skeletal system may enhance bone depletion.
In conclusion, the increased bone resorp tion in paraplegic patients is followed by an increase of serum osteocalcin demonstrating an enhanced osteoblastic activity. Immobil isation and loss of muscular activity follow ing acute spinal cord injury in previously healthy males thus lead to a severe de terioration of bone metabolism.
